Navigation Judges Hear 1st Challenge to Medicare Drug Price Program to Hit Federal Appeals Court
The challenge to the program seems to be a part of a larger legal strategy to create a circuit split, thus increasing chances of U.S. Supreme Court review, said Andrew Twinamatsiko, director of the Health Policy and the Law Initiative at the O’Neill Institute.
